On the basis of the past reports about MK expression in ageing-related diseases, it is natural to consider that expression of MK is elevated in the presymptomatic stages of diseases, such as asymptomatic cerebral infarction, asymptomatic ischemic heart diseases, and a pathological prestage of Alzheimer's disease. The gene discussed is MDK; the disease is glycogen storage disease VI.